JP2008517900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517900A5 JP2008517900A5 JP2007537422A JP2007537422A JP2008517900A5 JP 2008517900 A5 JP2008517900 A5 JP 2008517900A5 JP 2007537422 A JP2007537422 A JP 2007537422A JP 2007537422 A JP2007537422 A JP 2007537422A JP 2008517900 A5 JP2008517900 A5 JP 2008517900A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- agent
- isd
- seq
- staphylococcus aureus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62192104P | 2004-10-25 | 2004-10-25 | |
| PCT/IB2005/004126 WO2006059247A2 (en) | 2004-10-25 | 2005-10-25 | VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517900A JP2008517900A (ja) | 2008-05-29 |
| JP2008517900A5 true JP2008517900A5 (https=) | 2008-12-18 |
Family
ID=36565416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007537422A Pending JP2008517900A (ja) | 2004-10-25 | 2005-10-25 | スタフィロコッカス−アウレウスＩｓｄたんぱく質ベースの抗感染薬 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1812066A4 (https=) |
| JP (1) | JP2008517900A (https=) |
| KR (1) | KR20070085457A (https=) |
| AU (1) | AU2005310981A1 (https=) |
| CA (1) | CA2581746A1 (https=) |
| WO (1) | WO2006059247A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8007811B2 (en) | 2005-02-14 | 2011-08-30 | Epitopix, Llc | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| AU2007281934B2 (en) * | 2006-01-18 | 2012-11-15 | University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
| EP2476433A1 (en) | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
| CA2667788A1 (en) * | 2006-10-30 | 2008-12-18 | The University Of Western Ontario | Staphylococcus aureus specific anti-infectives |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| JP5658564B2 (ja) | 2007-08-31 | 2015-01-28 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物 |
| WO2010014304A1 (en) | 2008-07-29 | 2010-02-04 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
| BRPI1011856A2 (pt) | 2009-03-23 | 2020-11-03 | Epitopix, Llc | polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso |
| HUE026855T2 (en) | 2009-04-03 | 2016-07-28 | Univ Chicago | Compositions and methods related to protein a (spa) variants |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| CA2803298C (en) | 2010-07-02 | 2020-07-14 | The University Of Chicago | Compositions and methods related to protein a (spa) variants |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| US9909123B2 (en) * | 2013-03-15 | 2018-03-06 | Techulon Inc. | Antisense molecules for treatment of Staphylococcus aureus infection |
| US9834768B2 (en) | 2014-12-31 | 2017-12-05 | Korea Advanced Institute Of Science And Technology | Effective method for specific gene silencing using artificial small RNA |
| US12514914B2 (en) | 2019-05-14 | 2026-01-06 | The University Of Chicago | Methods and compositions comprising Staphylococcus protein a (SpA) variants |
| CN114929750B (zh) | 2019-09-13 | 2024-11-22 | 芝加哥大学 | 用于治疗葡萄球菌感染的方法和组合物 |
| CN120943954B (zh) * | 2025-10-20 | 2026-02-06 | 重庆原伦生物科技有限公司 | 抗金黄色葡萄球菌IsdB抗体的制备及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002306849A1 (en) * | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| MXPA03011701A (es) * | 2001-06-15 | 2004-12-06 | Nhibitex Inc | Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus. |
| ATE542829T1 (de) * | 2001-08-02 | 2012-02-15 | Univ Sheffield | Impfstoff |
| KR20060065643A (ko) * | 2003-07-24 | 2006-06-14 | 머크 앤드 캄파니 인코포레이티드 | 스타필로코쿠스 아우레우스에 대한 방어 면역 반응을유도하는 폴리펩타이드 |
| NZ553776A (en) * | 2004-09-22 | 2010-05-28 | Glaxosmithkline Biolog Sa | Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide. |
-
2005
- 2005-10-25 AU AU2005310981A patent/AU2005310981A1/en not_active Abandoned
- 2005-10-25 EP EP05850805A patent/EP1812066A4/en not_active Withdrawn
- 2005-10-25 CA CA002581746A patent/CA2581746A1/en not_active Abandoned
- 2005-10-25 JP JP2007537422A patent/JP2008517900A/ja active Pending
- 2005-10-25 WO PCT/IB2005/004126 patent/WO2006059247A2/en not_active Ceased
- 2005-10-25 KR KR1020077011878A patent/KR20070085457A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008517900A5 (https=) | ||
| CA2909080C (en) | Methods, uses and compositions of tie2 agonists | |
| JP2008536483A5 (https=) | ||
| JP2002542798A5 (https=) | ||
| JP2008546390A5 (https=) | ||
| JP2012092117A (ja) | Ｉｌ−２３活性を調節する方法；関連する試薬 | |
| JP2006519605A5 (https=) | ||
| RU2012107993A (ru) | Полипептиды porhyromonas gingivalis | |
| JP2012522010A5 (https=) | ||
| JP2010530238A5 (https=) | ||
| AU2019205602A1 (en) | Peptides having protease activity for use in the treatment or prevention of coronavirus infection | |
| JP2009545526A5 (https=) | ||
| US20240218059A1 (en) | TGF-Beta 1 INHIBITORS FOR PREVENTING AND TREATING SARS-COV-2 | |
| WO2012102793A2 (en) | Mammalian genes involved in toxicity and infection | |
| WO2016079321A1 (en) | Antagonists of setdb2 for use in the therapy of infectious diseases | |
| CN107849106A (zh) | 融合分子 | |
| JP2016520570A (ja) | Ａ型インフルエンザウイルス感染の治療又は予防に使用するためのｐａｒ−４アンタゴニスト | |
| Herrera et al. | The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF. 2 contributes to virulence in an influenza superinfection | |
| KR20010052244A (ko) | Ｎ-말단 콜린 결합 단백질 ａ 절단물의 아미노산을포함하는 폴리펩티드, 이로부터 유도된 백신 및 이의 용도 | |
| US20120058127A1 (en) | PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections | |
| Zhao et al. | A broad-spectrum virus-and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory viruses | |
| KR20110005710A (ko) | 변형된 Ｃｐｎ10 및 ＰＲＲ 시그널링 | |
| Guenther et al. | Modulation of lung inflammation by the Epstein-Barr virus protein Zta | |
| JP2009526861A5 (https=) | ||
| JP2008514196A5 (https=) |